Catalase Application in Cancer Therapy: Simultaneous Focusing on Hypoxia Attenuation and Macrophage Reprogramming Publisher Pubmed



Najafi A^{1, 2} ; Keykhaee M³ ; Khorramdelazad H² ; Karimi MY⁴ ; Nejatbakhsh Samimi L^{1, 2} ; Aghamohamadi N^{1, 2} ; Karimi M^{1, 2} ; Falak R^{1, 2} ; Khoobi M^{3, 5} Show Affiliations
Source: Biomedicine and Pharmacotherapy Published:2022

Abstract

The tumor microenvironment (TME), as an immunosuppressive milieu, has a critical role in tumor progression and increases resistance to the conventional treatments. Among the abundant immunosuppressive cells in the TME, tumor-associated macrophages (TAMs) could be a promising target for reprogramming and potentiating the local anti-tumor response. On the other hand, hypoxia is a major barrier in treating solid tumors, which aggravates the situation and alleviates the anti-tumor immune responses. Moreover, catalase and catalase-mimicking compounds can efficiently participate in the TAMs polarization and hypoxia attenuation in the TME. In this review, we will introduce a practical and novel approach which can simultaneously reduce hypoxia and polarize TAMs in the TME. Furthermore, catalase therapeutic effects in combination with cancer therapy methods will be fully discussed. This work aims to inspire readers to explore new avenues for designing and development of next-generation catalase-based formulations for cancer therapy. © 2022 The Authors